Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Chỉ hiển thị Multimedia
OnabotulinumtoxinA as effective as, safer than pharmacotherapy for OAB
02 Oct 2025
bởiStephen Padilla
Women with refractory overactive bladder (OAB) may improve their symptoms by using either intradetrusor onabotulinumtoxinA or combined pharmacotherapy with solifenacin and mirabegron, suggests a study.
OnabotulinumtoxinA as effective as, safer than pharmacotherapy for OAB
02 Oct 2025
JAK inhibitor a new hope for new-onset T1D?
02 Oct 2025
bởiAudrey Abella
The 2-year outcomes from the phase II BANDIT* trial confirm the potential of the Janus kinase (JAK) inhibitor baricitinib for the treatment of new-onset type 1 diabetes (T1D).
